We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Freshworks
FRSH
$3.62B
| $870K | ﹤0.01% |
58,377
+17,318
| +42% | +$250K |
|
1177
Olin
OLN
$1.95B
| $867K | ﹤0.01% |
43,161
+32,205
| +294% | +$669K |
|
1178
Crane Co
CR
$12B
| $866K | ﹤0.01% |
4,562
-44
| -1% | -$7.3K |
|
1179
Paylocity
PCTY
$8.38B
| $864K | ﹤0.01% |
4,770
-45
| -0.9% | -$8.45K |
|
1180
Cigna
CI
$73.7B
| $864K | ﹤0.01% |
2,614
-882
| -25% | -$284K |
|
|
OPTU
1181
Optimum Communications Inc
OPTU
$389M
| $863K | ﹤0.01% |
403,370
-3,300
| -0.8% | -$7.74K |
|
1182
Omega Healthcare
OHI
$13.9B
| $859K | ﹤0.01% |
23,444
+244
| +1% | +$9.06K |
|
1183
Fabrinet
FN
$14.8B
| $859K | ﹤0.01% |
2,915
-8
| -0.3% | -$1.78K |
|
1184
Zions Bancorporation
ZION
$9.89B
| $858K | ﹤0.01% |
16,510
+2,508
| +18% | +$118K |
|
1185
HUB Group
HUBG
$2.42B
| $858K | ﹤0.01% |
25,651
-936
| -4% | -$31.4K |
|
1186
Avantor
AVTR
$9.86B
| $856K | ﹤0.01% |
63,613
-259,460
| -80% | -$3.55M |
|
1187
Ecovyst
ECVT
$1.11B
| $855K | ﹤0.01% |
103,900
-18,470
| -15% | -$130K |
|
1188
RLJ Lodging Trust
RLJ
$1.75B
| $851K | ﹤0.01% |
116,843
+10,868
| +10% | +$78.3K |
|
|
SVCO
1189
Silvaco Group
SVCO
$232M
| $850K | ﹤0.01% |
180,000
+54,000
| +43% | +$256K |
|
1190
New York Times
NYT
$11B
| $848K | ﹤0.01% |
15,148
-303
| -2% | -$16.1K |
|
1191
Frontdoor
FTDR
$5.71B
| $847K | ﹤0.01% |
14,376
-88,318
| -86% | -$4.43M |
|
1192
Bloom Energy
BE
$62.1B
| $847K | ﹤0.01% |
+35,409
| New | +$686K |
|
1193
Healthcare Realty
HR
$6.51B
| $847K | ﹤0.01% |
53,385
+11,993
| +29% | +$182K |
|
1194
American Financial Group
AFG
$11.9B
| $846K | ﹤0.01% |
6,705
-134
| -2% | -$16.8K |
|
1195
MasterBrand
MBC
$1.76B
| $845K | ﹤0.01% |
+77,275
| New | +$855K |
|
|
MRC
1196
DELISTED
MRC Global
MRC
| $844K | ﹤0.01% |
61,549
-41,287
| -40% | -$498K |
|
1197
Primerica
PRI
$8.94B
| $839K | ﹤0.01% |
3,067
-93
| -3% | -$24.6K |
|
1198
ONE Gas
OGS
$5B
| $836K | ﹤0.01% |
11,627
+4,973
| +75% | +$374K |
|
1199
OGE Energy
OGE
$9.45B
| $835K | ﹤0.01% |
18,826
-232
| -1% | -$10.3K |
|
1200
CVB Financial
CVBF
$3.91B
| $834K | ﹤0.01% |
42,133
+7
| +0% | +$130 |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.